Morphine Sulfate Solution
NDC Package 0406-8003-30
Package Information
Morphine Sulfate solution is morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL) is indicated for use in opioid-tolerant adult patients who require higher doses of opioids for the management of pain severe enough to require an opioid analgesic and for which alternate treatments are inadequate.Limitations of Use:Because of the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosage or duration and persist over the course of therapy [see Warnings and Precautions (5.2)], reserve opioid analgesics, including morphine sulfate oral solution, for use in patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. This formulation utilizes a solution delivery system. Marketed by Specgx Llc, this product is identified by NDC 0406-8003 and is authorized under FDA application ANDA202348.
Identification & Billing
- RxCUI: 892625 - morphine sulfate 20 MG in 1 mL Concentrate for Oral Solution
- RxCUI: 892625 - morphine sulfate 20 MG/ML Oral Solution
- RxCUI: 892625 - morphine sulfate 10 MG per 0.5 ML Concentrate for Oral Solution
- RxCUI: 892625 - morphine sulfate 100 MG per 5 ML Concentrate for Oral Solution
- RxCUI: 892625 - morphine sulfate 20 MG/ML Concentrate for Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0406 - Specgx Llc
- 0406-8003 - Morphine Sulfate
- 0406-8003-30 - 6 CARTON in 1 CASE / 1 BOTTLE, PLASTIC in 1 CARTON / 30 mL in 1 BOTTLE, PLASTIC
- 0406-8003 - Morphine Sulfate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0406-8003). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0406-8003-30 identifies a specific commercial package of 6 carton in 1 case / 1 bottle, plastic in 1 carton / 30 ml in 1 bottle, plastic of Morphine Sulfate, a human prescription drug labeled by Specgx Llc. This solution is formulated for oral use and contains morphine sulfate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Specgx Llc on July 15, 2011. The current certification is valid through December 31, 2027.
How is this Specgx Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00406800330. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 180 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.